IL-12 and IL-23 pathway inhibition in inflammatory bowel disease
IL-12 and IL-23 pathway inhibition in inflammatory bowel disease is a paper indexed in ScholarIQ from OpenAlex.
How many citations does IL-12 and IL-23 pathway inhibition in inflammatory bowel disease have?
IL-12 and IL-23 pathway inhibition in inflammatory bowel disease has 244 citations in the OpenAlex counts ScholarIQ stores.
When was IL-12 and IL-23 pathway inhibition in inflammatory bowel disease published?
IL-12 and IL-23 pathway inhibition in inflammatory bowel disease has 2023 year in the ScholarIQ index.
What is the open-access status of IL-12 and IL-23 pathway inhibition in inflammatory bowel disease?
IL-12 and IL-23 pathway inhibition in inflammatory bowel disease has green oa status in the ScholarIQ index.
What is the DOI of IL-12 and IL-23 pathway inhibition in inflammatory bowel disease?
The DOI for IL-12 and IL-23 pathway inhibition in inflammatory bowel disease is on the source record.
What is the PMID of IL-12 and IL-23 pathway inhibition in inflammatory bowel disease?
The PMID for IL-12 and IL-23 pathway inhibition in inflammatory bowel disease is on the source record.
What is the OpenAlex record for IL-12 and IL-23 pathway inhibition in inflammatory bowel disease?
The OpenAlex for IL-12 and IL-23 pathway inhibition in inflammatory bowel disease is on the source record.